Brookmont Capital Management Boosts Stake in Johnson & Johnson Amid Strong Earnings
Brookmont Capital Management has increased its stake in Johnson & Johnson by 38.6% in the second quarter, according to a recent SEC filing.
The fund now owns 14,249 shares of JNJ's stock after purchasing an additional 3,968 shares during the period. The investment is worth approximately $3,619,000 and makes up about 1.9% of Brookmont Capital Management's portfolio.
This is not the only significant move made by institutional investors in JNJ recently. Vanguard Group Inc. has increased its holdings in Johnson & Johnson by 1.6%, while State Street Corp grew its stake by 1.3%. Auto Owners Insurance Co has also boosted its position in shares of Johnson & Johnson by a staggering 22,225.6%.
In related news, JNJ recently exceeded quarterly EPS and revenue expectations, with revenue rising 6.6% year over year. The company's FY 2026 guidance is set at $11.60, $11.75 EPS, and analysts continue to rate the stock favorably ahead of third-quarter earnings.